<scp>SARS‐CoV</scp>‐2 vaccination status and adverse events among patients with psoriasis—Data from the German Registries <scp>PsoBest</scp> and <scp>CoronaBest</scp>-Reference-Cited by-同舟云学术

SARS‐CoV‐2 vaccination status and adverse events among patients with psoriasis—Data from the German Registries PsoBest and CoronaBest

Published:2023-03-27 Issue:7 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Valencia López María José¹,Meineke Anna¹,Stephan Brigitte¹^ORCID,Rustenbach Stephan Jeff¹,Kis Anne¹,Thaçi Diamant²,Mrowietz Ulrich³^ORCID,Reich Kristian¹,Staubach‐Renz Petra⁴,von Kiedrowski Ralph⁵,Bogena Henriette¹,Augustin Matthias¹^ORCID

Affiliation:

1. Institute for Health Services Research in Dermatology and Nursing (IVDP) University Medical Center Hamburg‐Eppendorf (UKE) Hamburg Germany

2. Institute and Comprehensive Center for Inflammation Medicine University of Lübeck Lübeck Germany

3. Psoriasis Center Kiel, Department of Dermatology Venereology and Allergology University Medical Center Schleswig‐Holstein Kiel Germany

4. Department of Dermatology and Allergy University Medical Center Mainz Mainz Germany

5. Dermatological Practice Selters Selters Germany

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19039

Reference6 articles.

1. GisondiP MrowietzU Garcia‐DovalI.Vaccination against SARS‐CoV‐2 in people with psoriasis disease. EuroGuiDerm Consensus statement ‐ Updated version January 2022.2022. Available at:https://derma.de/fileadmin/PDF‐Dateien/EuroGuiDerm_Pso_SarsCov2Vacc_April2021.pdf. Accessed 21 September 2022.

2. Impfen bei Immundefizienz

3. Aktueller Impfstatus.2022. Available at:https://www.impfdashboard.de. Accessed 18 November 2022.

4. Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents

5. Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial;Vaccines;2024-01-11

2. PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy;Journal of the European Academy of Dermatology and Venereology;2023-12-07

3. Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real‐world practice;Experimental Dermatology;2023-07-20